Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)
Clinical trial NCT01945294 · COMPLETED
Trial details
- NCT number
- NCT01945294
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-10
- Primary completion
- 2015-08-05
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.